Arcutis Biotherapeutics Inc. logo

Arcutis Biotherapeutics Inc.

ARQT | NASDAQ
Chart Builder DCF Calculator
$25.96
+$0.58 (+2.29%)
At close: Sep 21, 2026, 4:00 PM ET
$25.96
$0 (0.00%)
Pre-market: Sep 22, 2026, 4:00 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-16.14M -140.04M -262.14M -311.46M -206.36M -135.68M
Depreciation & Amortization
4.67M 2.6M 1.52M 934K 454K 122K
Stock-Based Compensation
40.36M 41.73M 38.81M 32.68M 23.89M 7.94M
Other Working Capital
47.36M 30.35M -3.68M 4.23M 3.38M 8.46M
Other Non-Cash Items
314K -1.37M -1.75M 30.3M 309K 333K
Deferred Income Tax
n/a n/a n/a n/a 3.45M 114K
Change in Working Capital
-34.83M -15.08M -23.5M -10.18M 3.62M 14.13M
Operating Cash Flow
-5.63M -112.16M -247.06M -257.72M -174.63M -113.03M
Capital Expenditures
-686K -143K -428K -23.28M -995K -321K
Cash Acquisitions
n/a n/a n/a 22.95M 74.96M 181.5M
Purchase of Investments
-246.99M -254.82M -225.84M -415.39M -292.51M -279.1M
Sales Maturities Of Investments
227.42M 288.78M 406.5M 351.47M 217.55M 97.6M
Other Investing Acitivies
-10M -5M n/a -22.95M -74.96M -181.5M
Investing Cash Flow
-30.25M 28.82M 180.23M -87.2M -75.95M -181.82M
Debt Repayment
n/a -100M n/a 125M 73.99M n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 4.52M 2.42M 751K 470K 1.14M
Financial Cash Flow
6.97M 66.2M 101.32M 301.8M 281.95M 298.15M
Net Cash Flow
-28.74M -17.37M 34.45M -43.12M 31.37M 3.29M
Free Cash Flow
-6.31M -112.3M -247.49M -281M -175.62M -113.35M
Adj. Free Cash Flow
-46.68M -154.03M -286.3M -313.68M -199.51M -121.3M
Maintenance CapEx
n/a n/a n/a -7.52M -454K -122K
Growth CapEx
-686K -143K -428K -15.76M -541K -199K
Owner Earnings
-5.63M -112.16M -247.06M -265.24M -175.08M -113.16M

© 2026 bestshares.com. All rights reserved.